Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network assessed interim 2018/19 vaccine effectiveness (VE) against predominant influenza A(H1N1)pdm09 viruses. Adjusted VE was 72% (95% confidence interval: 60 to 81) against medically attended, laboratory-confirmed influenza A(H1N1)pdm09 illness. This substantial vaccine protection was observed in all age groups, notably young children who appeared to be disproportionately affected. Sequence analysis identified heterogeneity in emerging clade 6B.1 viruses but no dominant drift variant.
All Keywords
【저자키워드】 Vaccines, Epidemiology, Influenza, Influenza virus, viral infections, Genomics, Laboratory, immunisation, influenza-like illness, Canada, vaccine effectiveness, vaccine-preventable diseases, ILI,
【저자키워드】 Vaccines, Epidemiology, Influenza, Influenza virus, viral infections, Genomics, Laboratory, immunisation, influenza-like illness, Canada, vaccine effectiveness, vaccine-preventable diseases, ILI,